Hahn Mark W's Form 4 filing
Verona Pharma plc (VRNA) · filed Aug 7, 2023
- Accession no.
- 0001104659-23-088491
- Filed
- Aug 7, 2023
- Trade date
- Aug 3-7, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $694.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hahn Mark WCIK 0001408502 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | Ordinary Shares | SSaleDisposed | −117,272 | $2.54F3 | −$297,870.88 | 15,679,864 | Direct | |
| Aug 4, 2023 | Ordinary Shares | SSaleDisposed | −150,000 | $2.50F3 | −$375,000 | 15,529,864 | Direct | |
| Aug 7, 2023 | Ordinary Shares | SSaleDisposed | −8,616 | $2.47F3 | −$21,281.52 | 15,521,248 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported represents the sale price of the ADSs divided by eight (8).
Referenced by the price of 3 transactions in Table I.